Personalizing immunosuppression in liver transplant recipients: Balancing rejection, infection and malignancy
Simone I. Strasser (AU)
Search Program
Search sessions, presentations, speakers, abstracts, and program topics.
Results for CCC
Monday, September 21, 2026
Room C4.1
Personalizing immunosuppression in liver transplantation: From microbiome to malignancy
Personalizing immunosuppression in liver transplantation: From microbiome to malignancy
Chairs
Jennifer Garcia (US) · Ashwin Rammohan (IN)
Room C4.6
Vasculopathy: A tale of three organs
Vasculopathy: A tale of three organs
Chairs
Hatem Amer (US) · Linda C. Cendales (US)
Matching presentations
Graft-localized programmable immunosuppression enables durable survival in vascularized composite allotransplantation
Vijay Gorantla (US)
What we know and don't but should about cardiac allograft vasculopathy
Kavitha Muthiah (AU)
What should we continue to learn from renal allograft pathology
Mariam Alexander (US)
Room C4.9
Local/Regional insights for global organ donation advancement
Local/Regional insights for global organ donation advancement
Room C4.9
Beyond survival: Addressing mental health in transplantation
Beyond survival: Addressing mental health in transplantation
Chairs
Lisa A. Coscia (US) · Geoffrey McCaughan (AU)
Matching presentations
Why survival alone is not sufficient for transplant successs
Mariel Nöhre (DE)
Psychological distress across the transplant journey
Iris Fontanilla (NZ)
Practical strategies for integrating mental health in transplant care
Ming Hwei Yek (US)
Panel Discussion
Discussion Period (AU)
Room C4.10
Dedicated donor care units: Centralized donor transfer and outcome optimization
Dedicated donor care units: Centralized donor transfer and outcome optimization
Chairs
David Thomson (ZA) · Dale Gardiner (GB)
Matching presentations
25 years of innovation: The St. Louis donor care unit
Gary F. Marklin (US)
The US donor care unit landscape
Jennifer Prinz (US)
The first comprehensive-DCU developed in China leading the change of the procurement model
Jixiang Liao (CN)
Panel Discussion
Discussion Period (AU)
Room C4.4
DCD: Controlled and uncontrolled—Where are we going?
DCD: Controlled and uncontrolled—Where are we going?
Chairs
Kenneth J. Woodside (US) · Mauricio Pereira (ES)
Matching presentations
Potential donors: Controlled and un-Controlled
Marti Manyalich Vidal (ES)
Role of ICU physicians
Sara Alcantara Carmona (ES)
Ethics for DCD: How to advance?
David Thomson (ZA)
Who should Canulate?
Lilia Martinez de la Maza (SE)
Which organs to implant, which ones to pump after NRP
Joaquim Albiol (ES)
Question Period
Discussion Period (AU)
Room C4.8
The -omic era in allograft pathology
The -omic era in allograft pathology
Chairs
Nancy Kwan Man (HK) · Joshua Lawrence Lee (AU)
Matching presentations
Does metabolic phenotype in the kidney affect transplant outcome?
Ana Konvalinka (CA)
Endogenous peptides in T cell allorecognition and beyond – Lessons from preclinical models
Alexandra Sharland (AU)
What metabolic interactions drives fibrosis and repair in organ transplantation?
Ton J. Rabelink (NL)
Room C4.9
Transplantation journals: Updates and opportunities
Transplantation journals: Updates and opportunities
Chairs
Stefan Tullius (US) · Fadi Issa (GB)
Matching presentations
Structure, achievements, goals – Getting your work published, recognized and highlighted
Stefan Tullius (US)
Transplant-Direct: The online campaign journal with an own agenda
Edward Geissler (DE)
AI and publishing: When, how and what is legit?
Germaine Wong (AU)
Room C4.1
The mentorship mosaic: Fostering growth in transplant training and practice
The mentorship mosaic: Fostering growth in transplant training and practice
Chairs
Sarah Tsou (US) · Natasha Rogers (AU)
Room C4.9
Building high-performing transplant registries: Global consensus recommendations and a practical maturity framework
Building high-performing transplant registries: Global consensus recommendations and a practical maturity framework
Chair
Sang Joseph Kim (CA)
Matching presentations
Opening remarks and overview: From fragmented data to global alignment. Why transplant registries need a shared framework
Sang Joseph Kim (CA)
Creating a transplant registry: Defining purpose, scope, and sustainable infrastructure
Germaine Wong (AU)
Establishing trust: Governance, ethics, and legal architecture of transplant registries
Axel Rahmel (DE)
Designing registries that work: Data architecture, harmonization, and operational feasibility
Jon Snyder (US)
Using registry data responsibly: Methodology, bias mitigation, and meaningful interpretation
Allan Massie (US)
From aspirational standards to practical assessment: Introducing the transplant registry maturity model
Yee Lu (US)
Panel Discussion
Discussion Period (AU)
Panelist
Nicole Jane Scholes-Robertson (AU)
Room C3.6
Advancing ABO histocompatibility: Needs and solutions
Advancing ABO histocompatibility: Needs and solutions
Chairs
Janette Kwok (HK) · Lucy Sullivan (AU)
Matching presentations
ABO antigens and antibodies: Updating old dogmas
Anne Halpin (CA)
Beyond HLA: Adaptive sequencing for blood group profiling in transplantation
Karen Sherwood (CA)
ABO incompatible kidney transplantation, strategies and successes
Marta Crespo Barrio (ES)
Room C4.2
Expanding donor access: The impact of ECMO in thoracic transplantation a TTS/ISHLT Conjunct Session
Expanding donor access: The impact of ECMO in thoracic transplantation a TTS/ISHLT Conjunct Session
Chairs
Pablo Sanchez (US) · Raj Ramanan (US)
Matching presentations
ECPR-driven growth in the donor pool
Alvaro Perazzo (BR)
Diagnosing brain death in the ECMO patient
Kavitha Muthiah (AU)
The role of NRP and machine perfusion in cardiothoracic transplantation
Sandra Lindstedt (SE)
Complex decisions: Ethical dilemmas of ECMO, DCD and NRP donors
Emily Granger (AU)
Cockle Bay 1
Sex, cancer, and the graft: What women need most from transplant care
Sex, cancer, and the graft: What women need most from transplant care
Chairs
Karen Keung (AU) · Nazia Selzner (CA)
Matching presentations
Do women do better or worse – What the data say across cancer and transplant?
Brenda Maria Rosales (AU)
Screening, hormones, and birth plans: a playbook for female recipients
Sakhee Kotecha (AU)
Post transplant care: Patient perspectives
Nicole Jane Scholes-Robertson (AU)
Room C3.3
Optimizing cardiometabolic health across the lifespan following transplantation
Optimizing cardiometabolic health across the lifespan following transplantation
Matching presentations
Introduction
Karen Dwyer (AU)
Introduction
Amanda Sluiter (AU)
Panelist
Nuria Montero (ES)
Panelist
Zhejia Tian (DE)
Panelists
Maria Simonenko (RU)
Panelist
Penny Figtree (AU)
Panelist
Emma Tumilty (AU)
Panelist
John Lafferty (AU)
Panelist
Patricia Scheetz (AU)
Moderator/Panelist
Karen Dwyer (AU)
Moderator/Panelist
Brenda Maria Rosales (AU)
Moderator/Panelist
Amanda Sluiter (AU)
Closing discussion
Karen Dwyer (AU)
Room C3.4-C3.5
Transplant without borders: Collaborative solutions for global kidney care
Transplant without borders: Collaborative solutions for global kidney care
Chairs
Germaine Wong (AU) · Medhat Askar (US)
Matching presentations
The global interdependence of health and the burden of kidney disease as a pressing public health priority
Benita Padilla (PH)
Transplant knowledge and skills transfer: the role of collaborative partnerships in reducing disparities in kidney disease-related morbidity and mortality
Shyam Bihari Bansal (IN)
Overcoming the challenges in achieving equity in global access to kidney transplantation
Beatriz Domínguez-Gil (ES)
Sustainable and scalable models for establishing kidney transplant programs in resource-limited contexts
John S. Gill (CA)
Tuesday, September 22, 2026
Room C4.1
Delivering value in liver transplantation: Innovation, resources, and the future of care
Delivering value in liver transplantation: Innovation, resources, and the future of care
Chairs
Gabriel E. Gondolesi (US) · Shantanu Bhattacharya (AU)
Matching presentations
Implementing change and managing resources: Can we do both?
Alfred Kow (SG)
Defining value in liver transplantation: Focusing on what matters
Julie K. Heimbach (US)
Telemedicine and remote monitoring: the potential of digital health tools to optimise patient care
Brooke Huuskes (AU)
Room C4.10
Pediatric treatments on the Horizon
Pediatric treatments on the Horizon
Chairs
Katherine E. Twombley (US) · Matthew Sypek (AU)
Room C4.4
The journey to clinical xenotransplantation
The journey to clinical xenotransplantation
Chairs
Leonardo Riella (US) · Evelyn Salvaris (AU)
Matching presentations
2025 Carl-Gustav Groth Xeno Prize for the paper on "Desensitization with Proteasome Inhibition and Costimulation Blockade Modulates the Xenoreactive Humoral Response in Nonhuman Primate Xenotransplantation"
Brendan P. Lovasik (US)
Development of the gene edited pigs to get us to the clinic
Peter Cowan (AU)
Avoiding dysregulation of the complement and coagulation-anticoagulation systems?
Jo Tector (US)
The road to regulatory approval for clinical transplantation
Muhammad Mohiuddin (US)
Room C4.9
Optimizing and utilizing old organ donors
Optimizing and utilizing old organ donors
Chairs
Helen Opdam (AU) · Jeffrey Orlowski (US)
Room C4.2
Life after transplant: Supporting movement, confidence, and long-term recovery across all levels of ability (WTGF)
Life after transplant: Supporting movement, confidence, and long-term recovery across all levels of ability (WTGF)
Chairs
Chris Thomas (AU) · Kate Wyburn (AU)
Matching presentations
The long-term transplant journey: What patients experience after discharge
Liz Schick (CH)
Movement when endurance is limited: Finding confidence through everyday activity
Geoff Jessup (AU)
From recovery to endurance sport: The transformative role of movement
Kate Clark (AU)
Clinical perspective: Encouraging safe physical activity after transplant
Geoffrey McCaughan (AU)
Panel discussion: Supporting all patients to move
Discussion Period (AU)
Room C4.5
Emerging infectious diseases in transplant ID
Emerging infectious diseases in transplant ID
Chairs
Olivia Smibert (AU) · Tina Marinelli (AU)
Matching presentations
Climate change and the changing epidemiology of transplant infections
Wanessa T. Clemente (BR)
On the move: Migration and the globalization of emerging pathogens
Monica Slavin (AU)
New outbreaks of old diseases: Measles and other re-emerging threats in transplantation
Cameron R. Wolfe (US)
Disease X and vaccine
Deepali Kumar (CA)
Room C4.8
Global collaboration in organ transplantation: Advancing ethical access, innovation, and sustainability
Global collaboration in organ transplantation: Advancing ethical access, innovation, and sustainability
Chairs
Rajdeep Das (US) · Marcelo Cantarovich (CA)
Matching presentations
Global organ sharing & research collaborations
Axel Rahmel (DE)
Economics of transplantation
Vasanthi Ramesh (IN)
Capacity building in low-resource settings
Medhat Askar (US)
Ethical, cultural & patient-centered considerations
Jeremy Chapman (AU)
Room C3.6
Precision immunosuppression and therapeutic optimization in transplantation: Kidney-centered advances across solid organ care
Precision immunosuppression and therapeutic optimization in transplantation: Kidney-centered advances across solid organ care
Chairs
Shyam Bihari Bansal (IN) · Yolanda Becker (US)
Room C4.7
Solving immune problems for the life of the allograft
Solving immune problems for the life of the allograft
Chairs
Xunrong Luo (CN) · Kieran Halloran (CA)
Matching presentations
Single cell transcriptomic profiling focusing on donor reactive T cells of operational tolerance recipient after liver transplantation
Naoki Tanimine (JP)
10-year outcomes for autologous polyclonal ex-vivo-expanded Treg cellular therapy in renal transplantation (ONE study UK Treg Trial)
Charlotte Yates (GB)
Single cell spatial technologies in kidney allograft pathology- inflammation, fibrosis and beyond
Mariam Alexander (US)
Direct and indirect allorecognition – more alike than we thought?
Gavin Pettigrew (GB)
Room C4.9
TTS-ISN: Pregnancy in renal transplant recipients - Outcomes, barriers, and clinical management
TTS-ISN: Pregnancy in renal transplant recipients - Outcomes, barriers, and clinical management
Chairs
Curie Ahn (KR) · Lisa A. Coscia (US)
Matching presentations
Assessing risk and overcoming barriers in pregnancy after kidney transplantation
Shilpanjali Jesudason (AU)
The pregnancy after renal transplantation OUTcomes registry (PARTOUT) in the Netherlands with granular data
Margriet de Jong (NL)
Supporting pregnancy in transplant recipients: current best practice care and controversies
Sumoyee Basu (GB)
Room C4.6
Multidisciplinary: Leveraging shared infrastructure for hematopoietic stem cell and solid organ transplantation
Multidisciplinary: Leveraging shared infrastructure for hematopoietic stem cell and solid organ transplantation
Chairs
Medhat Askar (US) · Marcelo Cantarovich (CA)
Matching presentations
The challenge of siloed program building vs. opportunities of integration
Markus Selzner (CA)
Immunologic bridge
Rajdeep Das (US)
One pathogen, two populations
Monica Slavin (AU)
Beyond the graft
Teun van Gelder (NL)
Panel discussion on global perspectives on integration and innovation
Discussion Period (AU)
Room C4.7
Approaching and navigating difficult conversations with transplant patients
Approaching and navigating difficult conversations with transplant patients
Chairs
David Thomson (ZA) · Lisa Keller (AU)
Matching presentations
Conversations around kidney transplant evaluation: Who and how to communicate non-eligibility for transplant
Rhiannon Reed (US)
Palliative care post-transplant: Throughout patient journey and symptom management
Kathryn Ducharlet (AU)
Navigating through organ failure to transplant: Liver transplant
Suk Kyun Hong (KR)
Navigating conversations on cardiac mechanical support therapy to heart transplant
Shunichi Nakagawa (US)
Hall 1-2
Poster Session 2
Poster Session 2
Wednesday, September 23, 2026
Room C3.6
Key components of an ideal high volume transplant program setup: A global surgical perspective
Key components of an ideal high volume transplant program setup: A global surgical perspective
Chairs
Dieter Broering (SA) · Meng Qingze (CN)
Room C4.1
Metabolic dysfunction and liver transplantation
Metabolic dysfunction and liver transplantation
Chairs
Julie K. Heimbach (US) · Geoffrey McCaughan (AU)
Matching presentations
Obesity, diabetes and MAFLD- A target or bystander?
Dinesh Jothimani (IN)
Getting the right patients to transplant: Patient selection, pre-transplant evaluation, and organ allocation in MAFLD
Kymberly Watt (US)
Optimising outcomes in patients with obesity after transplant: lifestyle modification, bariatric surgery or lifelong GLP1 therapy?
Marina Berenguer (ES)
Room C4.8
CMV and BK virus in transplant recipients: Pearls from the guidelines and emerging frontiers
CMV and BK virus in transplant recipients: Pearls from the guidelines and emerging frontiers
Chairs
Wanessa T. Clemente (BR) · Jeremy Chapman (AU)
Matching presentations
Pearls from the BK guidelines
Nassim Kamar (FR)
Pearls from the CMV guidelines
Camille N. Kotton (US)
Beyond the guidelines- new developments and future directions: BK
Germaine Wong (AU)
Beyond the guidelines - new developments and future directions: CMV
Atul Humar (CA)
Panel discussion: challenging BK case, challenging CMV case
Discussion Period (AU)
Room C4.1
From allorecognition to allocation: Moving toward more individualized kidney transplant matching
From allorecognition to allocation: Moving toward more individualized kidney transplant matching
Chairs
Janette Kwok (HK) · Rhonda Holdsworth (AU)
Room C4.10
Transplantation beyond traditional publications
Transplantation beyond traditional publications
Chairs
Stefan Tullius (US) · Macey L. Levan (US)
Matching presentations
Special features: A reality check on opportunities and challenges
Fadi Issa (GB)
Social media: Are we reaching our audience and readership worldwide
Jasper Iske (DE)
Editorial fellowships: A great opportunity to be involved
Melanie Wyld (AU)
Topic highlights – Article series
Camille N. Kotton (US)
Panel discussion
Discussion Period (AU)
Panelist
Khushboo Saxena (IN)
Room C4.9
Expanding horizons in pancreas transplantation: Outcomes, techniques, and program development
Expanding horizons in pancreas transplantation: Outcomes, techniques, and program development
Chairs
Pablo Uva (AR) · Toby Coates (AU)
Matching presentations
Current status of pancreas transplantation: Activity and outcomes around the world
Angelika C. Gruessner (US)
Donation after circulatory death (DCD) in pancreas transplantation: Logistics, use of normothermic regional perfusion (NRP) and outcomes
Joana Ferrer (ES)
Future of pancreas transplantation in the landscape of emerging therapies
Raja Kandaswamy (US)
Room C3.4-C3.5
Pediatric cholestatic liver disease around the world
Pediatric cholestatic liver disease around the world
Chairs
Gabriel E. Gondolesi (US) · Manuel Rodriguez-Davalos (US)
Matching presentations
Biliary atresia - whats happening in Latin America. Access to KPE and transplantation
Monserrat Arreola Gutierrez (MX)
Alagille syndrome - past, present and future
Susan Mei-Ling Siew (AU)
Progressive familiar intrahepatic cholestasis differences around the world and the role of medical vs. surgical therapy
Mohamed Rela (IN)
Primary sclerosing cholangiotis in children and adolescent
Michael Stormon (AU)
Room C4.11
Organ donation following MAID (VAD/euthanasia)
Organ donation following MAID (VAD/euthanasia)
Chairs
Peggy John (CA) · Helen Opdam (AU)
Matching presentations
Canadian donation perspective
Matthew Weiss (CA)
Australian donation perspective
Wade Stedman (AU)
New Zealand donation perspective
Kim Grayson (NZ)
Australian MAID/VAD provider perspective
Sara Townend (AU)
Panel discussion and Q&A
Discussion Period (AU)